Delivery Order SPE2DB22D2211-SPE2DB25FSDYV
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of 1,000 tablets of Januvia 100 mg, with a ceiling value of $10,411.20 and an ultimate completion date of August 5, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Januvia 100 mg tablets (90-count packages) under a firm fixed-price contract with a ceiling value of $3.9K. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1B global pharmaceutical support vehicle running through December 2026. The award was made through open...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,637.19 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count package) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,091.46 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement for pharmaceutical supply to federal medical systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order under its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,546.29 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Januvia 100 mg, a diabetes medication. The contract was executed on August 5, 2025, with an ultimate completion date of August 6, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,255.09 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed price contract type. The award was issued on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents a non-competitive set-aside delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Januvia 100 mg tablets (90-count) with a ceiling value of $9,111.37. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The delivery order was...
- The Defense Logistics Agency awarded a $2,187.36 delivery order to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime vendor agreement serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Januvia 50 mg tablets (90-count packages) under a firm fixed-price contract with a ceiling value of $1,124.61. This non-set-aside competitive award represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract valued at $1,091.46. The award represents a non-competitive delivery order executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. Performance will be completed...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDYVDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of 1,000 tablets of Januvia 100 mg, with a contract ceiling value of $50,372.45 and a firm fixed-price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 2, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $1 billion global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company has demonstrated extensive capability in fulfilling federal medical supply requirements through multiple competitively awarded contracts with the DLA, supplying diverse pharmaceutical products across numerous therapeutic domains. This delivery order for Januvia, a diabetes management medication, represents a routine fulfillment under the company's established prime vendor contract and reflects AmerisourceBergen's ongoing role as a primary supplier for military and federal healthcare pharmaceutical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $50.4k | 8/29/25 |